Selitrectinib (LOXO-195)

Selitrectinib (LOXO-195, BAY 2731954) is an orally available, highly potent, and selective TRK kinase inhibitor with low nanomolar inhibitory activity against TRKA G595R, TRKC G623R, and TRKA G667C, IC50s ranging from 2.0 to 9.8 nmol/L. It is more than 1,000-fold selective for 98% of non-TRK kinases tested.
Supplier Selleck Chemicals
Product # S8636
Sku # S8636-10mM/1mL
Pricing 10mM/1mL, $157.00
Feedback